diethylnitrosamine has been researched along with celastrol in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 1 (50.00) | 2.80 |
| Authors | Studies |
|---|---|
| Chang, W; He, W; Li, PP; Lu, JT; Song, SS; Wei, W; Yuan, PF | 1 |
| El-Ahwany, E; El-Kader, EMA; Ghanim, AMH; Saber, S | 1 |
2 other study(ies) available for diethylnitrosamine and celastrol
| Article | Year |
|---|---|
Protective effects of Celastrol on diethylnitrosamine-induced hepatocellular carcinoma in rats and its mechanisms.
Topics: Animals; Antineoplastic Agents; bcl-2-Associated X Protein; bcl-X Protein; Carcinogenesis; Carcinoma, Hepatocellular; Caspase 3; Caspase 9; Cytochromes c; Diethylnitrosamine; Gene Expression Regulation, Neoplastic; Liver; Liver Neoplasms; Male; Matrix Metalloproteinase 2; Matrix Metalloproteinase 9; Mitochondria; Pentacyclic Triterpenes; Poly(ADP-ribose) Polymerases; Proto-Oncogene Proteins c-mdm2; Rats; Rats, Sprague-Dawley; Triterpenes; Tumor Suppressor Protein p53 | 2016 |
Novel complementary antitumour effects of celastrol and metformin by targeting IκBκB, apoptosis and NLRP3 inflammasome activation in diethylnitrosamine-induced murine hepatocarcinogenesis.
Topics: Animals; Antineoplastic Agents; Apoptosis; Carcinogenesis; Carcinoma, Hepatocellular; Diethylnitrosamine; I-kappa B Kinase; Inflammasomes; Liver Neoplasms; Male; Metformin; Mice; Mice, Inbred BALB C; NF-kappa B; NLR Family, Pyrin Domain-Containing 3 Protein; Pentacyclic Triterpenes; Signal Transduction; Triterpenes | 2020 |